Form 4 for AXGN Axogen, Inc.
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-15 · accession 0000805928-21-000172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-17 | 2021-12-15 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $3.67 | +10.0K | 90.4K | +12% | +$36.7K |
| D | 2021-12-17 | 2021-12-15 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $8.80 | -4,171 | 86.3K | -5% | -$36.7K |
| D | 2021-12-17 | 2021-12-15 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-15 | M | A | 10,000 | $3.67 | 90,426 | D | — | — | (F1) This reflects the number of shares that became vested as of December 29, 2018. |
| 2 | Common | Common Stock | 2021-12-15 | F | D | 4,171 | $8.80 | 86,255 | D | — | — | (F2) Represents the number of shares swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule16b-3. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-12-15 | M | D | 10,000 | $0.00 | 0 | D | $3.67 · 2018-12-29 to 2021-12-29 | 10,000 Common Stock |